Executive Summary
Glucagon Like Peptide-1 Human Recombinant Recombinant Human GLP-1 is a 3.3 kDa polypeptideconsisting of 31 amino acid residues. This product is shipped at ambient temperature. For storage, handling and
Glucagon-like peptide-1, commonly abbreviated as GLP-1, is a crucial peptide hormone that plays a significant role in glucose metabolism and homeostasis. Derived from the proglucagon gene, GLP-1 is primarily secreted by intestinal L cells following food intake. Its multifaceted functions have positioned it as a key area of research, particularly in the context of Type II diabetes mellitus and obesity. Companies like PeproTech are instrumental in providing high-quality recombinant human glucagon-like peptide (GLP)-1 proteins, enabling scientists to conduct vital research into its therapeutic potential.
The Physiology and Function of GLP-1
Glucagon-like peptide-1 (GLP-1) is a potent incretin hormone, meaning it amplifies the insulin response after a meal. Its physiological functions are diverse and include:
* Stimulating insulin secretion: GLP-1 increases insulin secretion from pancreatic beta cells in a glucose-dependent manner. This means it promotes insulin release when blood glucose levels are high, thereby helping to lower them, but it does not typically cause hypoglycemia when glucose levels are normal.
* Decreasing glucagon secretion: Conversely, GLP-1 suppresses the secretion of glucagon, another pancreatic hormone that raises blood glucose levels. This dual action on insulin and glucagon contributes significantly to its glucose-lowering effects.
* Slowing gastric emptying: GLP-1 also slows down the rate at which food leaves the stomach, which can contribute to feelings of fullness and reduce post-meal glucose spikes.
* Promoting satiety: By influencing appetite regulation centers in the brain, GLP-1 can promote satiety, potentially aiding in weight management.
The GLP-1 molecule itself exists in several forms, with GLP-1 (7-37) being a truncated, bioactive form produced by proglucagon processing. Another important form is GLP-1(7-36), amide. The Glucagon-like peptide-1 (GLP-1) receptor, known as GLP1R, is a critical G-protein-coupled receptor involved in these processes. GLP1R is expressed in various tissues, including the pancreas, lung, heart, kidney, hypothalamus, and stomach, and is a key target in diabetes and metabolic research.
Recombinant GLP-1 and PeproTech's Contribution
For researchers to accurately study the effects and potential applications of GLP-1, access to pure and reliable recombinant proteins is essential. PeproTech, a well-known supplier in the biotechnology field, offers Human GLP-1 Recombinant Protein. These recombinant proteins are produced through biotechnological processes, ensuring a consistent and high-purity supply for various research applications.
The recombinant human glucagon-like peptide 1 provided by companies like PeproTech can be used to measure GLP-1 levels or activity in laboratory settings. The Gibco Human GLP-1 Recombinant Protein, PeproTech 1 mg is an example of such a product, offering a specific quantity for experimental use. These proteins are often characterized by their amino acid sequence and purity, with Glucagon Like Peptide-1 Human Recombinant typically being a single, non-glycosylated, polypeptide chain containing 31 amino acids and having a molecular mass of approximately 3.3 kDa. Some sources also describe Human GLP-1 peptide as a single, glycosylated, polypeptide chain containing 30 amino acids.
Therapeutic Potential and Research Avenues
The profound effects of GLP-1 on glucose regulation have led to its development as a therapeutic agent. Glucagon-like peptide-1 receptor agonists have proven to be an effective treatment for Type 2 diabetes and obesity, offering significant benefits to patients. Medications like Ozempic, for instance, are based on the action of GLP-1 analogs.
Research continues to explore the full potential of GLP-1 and its analogs. This includes investigating novel GLP-1 research peptides where to buy for in-depth studies, understanding the Glucagon like peptide glp 1 peprotech structure, and exploring its role in other physiological processes. The development of Albugon, a human glucagon-like peptide (GLP)-1-albumin recombinant protein, exemplifies innovative approaches to extend the half-life and enhance the therapeutic efficacy of GLP-1.
Furthermore, research into understanding GIP and GLP-1, the two incretin hormones: Similarities and differences is ongoing, as is the investigation of the Glucagon Like Peptide-1 Receptor (GLP1R) and its role in cellular signaling. The availability of recombinant GLP1 protein from reputable suppliers like PeproTech is crucial for advancing our understanding of this vital peptide hormone and developing new strategies for managing metabolic diseases. The study of glp-1 protein in various model organisms, such
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
